January 29, 2016 – 11:42 pm
Jeffrey Shuren, M.D., J.D., the Director of the Center for Device and Radiological Health at the Food and Drug Administration, replied to an open letter from the Leiomyoma Morcellation Review Group. You can read the original open letter here, and view Dr. Shuren’s reply in the images below. The Leiomyoma Morcellation Review Group sent the […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, ovarian cancer, power morcellator
|
December 8, 2015 – 5:00 pm
In November, 2014 the FDA ruled that power morcellation was contra-indicated in “the majority of women” having surgery for uterine fibroids due to the potential risk of spreading occult uterine sarcoma. Although problems with this ruling were immediately apparent, the passage of time has allowed for more clarity on the related medical issues. Prevalence of […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, no hysterectomy, ovarian cancer, power morcellator
|
August 19, 2014 – 10:01 am
Some people have recently suggested that all women have biopsies of their fibroids before surgery to determine which women have typical fibroids and which women might have a leiomyosarcoma (LMS). There are many problems with this idea. To start, I am going to use the word tumor throughout this post. When we hear” tumor”, most […]
A recent article in the Journal of the American Medical Association (JAMA) reported that the rate of uterine cancer among women having surgical procedures using morcellation was 1 woman out of 368. Since the recent FDA hearing was about morcellation and the risk of finding uterine leiomyosarcoma (LMS), some of the media have misinterpreted this […]
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroids, laparoscopic myomectomy, laparoscopy, LMS, Morcellation, morcellation risks, myomectomy, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy, uterine leiomyosarcoma
|
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.